Form 8-K - Current report:
SEC Accession No. 0000850261-19-000024
Filing Date
2019-06-17
Accepted
2019-06-17 09:22:27
Documents
130
Period of Report
2019-06-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-krexsegmentation.htm 8-K 46585
2 EXHIBIT 23.1 exhibit231consent8-k.htm EX-23.1 3704
3 EXHIBIT 99.1 exhibit991-8xksegmentation.htm EX-99.1 1706754
10 car-ta02.jpg GRAPHIC 121441
11 cohort1a03.jpg GRAPHIC 94095
12 flagshipa02.jpg GRAPHIC 163279
13 gmabpla02.jpg GRAPHIC 110847
14 sofusaa04.jpg GRAPHIC 113205
15 sorrentoimage2a06.jpg GRAPHIC 26870
16 srnepartnersa06.jpg GRAPHIC 182628
17 ztlidoa02.jpg GRAPHIC 314850
  Complete submission text file 0000850261-19-000024.txt   14534759

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT srne-20190617.xml EX-101.INS 2500772
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20190617.xsd EX-101.SCH 113153
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20190617_cal.xml EX-101.CAL 152233
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20190617_def.xml EX-101.DEF 863477
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20190617_lab.xml EX-101.LAB 1315579
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20190617_pre.xml EX-101.PRE 1025102
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 19900594
SIC: 8731 Services-Commercial Physical & Biological Research